Considering that promoting neutrophil migration into the site of inflammation is critical for strengthening the cross-talk between neutrophils and Th17 cells, finding new inducers for increasing production of IL-8, a strong chemoattractant for neutrophil recruitment, is critical for developing a new strategy for RA treatment. The gene discussed is CXCL8; the disease is rheumatoid arthritis.